Literature DB >> 8799581

Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells.

P Bois1, J Bescond, B Renaudon, J Lenfant.   

Abstract

1. The effect of the bradycardic agent S 16257 on the main ionic mechanisms of diastolic depolarization in sinoatrial node cells isolated from rabbit heart, was investigated by the patch-clamp technique in whole-cell and macro-patch recordings. 2. In whole-cell conditions, S 16257 induced a marked exponential use-dependent blockade of the hyperpolarization-activated I(f) current, without shift of the voltage range of its activation curve. The rate of block increased with the drug concentration. The IC50 for the block of I(f) was 2.8 x 10(-6) M. 3. A similar use-dependent decline of I(f) was obtained with 3 microM S 16257, in cell-attached and in inside out macro-patch configurations, suggesting that the bradycardic agent interacts with I(f) channels from the inside of the cell. 4. A high concentration of S 16257 (10 microM) had no detectable effect on T-type calcium current and slightly decreased L-type calcium current (-18.12 +/- 0.66%), without significant use-dependent blockade. 5. S 16257 had no effect on the delayed outward potassium current Ik at 3 microM and slightly decreased it only at high concentrations, -16.3 +/- 1.2% at 10 microM. In contrast, zatebradine, another bradycardic agent, reduced I k by 20.3 +/- 2.5% at 3 microM. 6. In conclusion, S 16257 may lower heart rate without significant negative inotropic action. In comparison with zatebradine, S 16257 had less effect on Ik suggesting less prolongation of repolarization time.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799581      PMCID: PMC1909508          DOI: 10.1111/j.1476-5381.1996.tb15505.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Evidence for two types of calcium currents in frog cardiac sinus venosus cells.

Authors:  P Bois; J Lenfant
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

2.  Acetylcholine inhibits activation of the cardiac hyperpolarizing-activated current, if.

Authors:  D DiFrancesco; C Tromba
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

3.  Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node.

Authors:  D DiFrancesco; A Ferroni; M Mazzanti; C Tromba
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

4.  Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.

Authors:  O Pérez; P Gay; L Franqueza; R Carrón; C Valenzuela; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

Review 5.  Cardiac pacemaking in the sinoatrial node.

Authors:  H Irisawa; H F Brown; W Giles
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

6.  Regulation of cardiac pacemaker current If in excised membranes from sinoatrial node cells.

Authors:  A Yatani; A M Brown
Journal:  Am J Physiol       Date:  1990-06

7.  Inhibitory actions of ZENECA ZD7288 on whole-cell hyperpolarization activated inward current (If) in guinea-pig dissociated sinoatrial node cells.

Authors:  R E BoSmith; I Briggs; N C Sturgess
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Mechanism of muscarinic control of the high-threshold calcium current in rabbit sino-atrial node myocytes.

Authors:  J Petit-Jacques; P Bois; J Bescond; J Lenfant
Journal:  Pflugers Arch       Date:  1993-04       Impact factor: 3.657

9.  Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells.

Authors:  N Hagiwara; H Irisawa; M Kameyama
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

10.  Muscarinic activation of ionic currents measured by a new whole-cell recording method.

Authors:  R Horn; A Marty
Journal:  J Gen Physiol       Date:  1988-08       Impact factor: 4.086

View more
  69 in total

Review 1.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

2.  An updated computational model of rabbit sinoatrial action potential to investigate the mechanisms of heart rate modulation.

Authors:  Stefano Severi; Matteo Fantini; Lara A Charawi; Dario DiFrancesco
Journal:  J Physiol       Date:  2012-06-18       Impact factor: 5.182

3.  Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

Authors:  Robinson Joannides; Nicholas Moore; Michaela Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

4.  HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in mice.

Authors:  Stefan Herrmann; Juliane Stieber; Georg Stöckl; Franz Hofmann; Andreas Ludwig
Journal:  EMBO J       Date:  2007-10-04       Impact factor: 11.598

5.  Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.

Authors:  R Zhang; A Haverich; M Strüber; A Simon; M Pichlmaier; Christoph Bara
Journal:  Clin Res Cardiol       Date:  2008-07-21       Impact factor: 5.460

6.  New evidence for coupled clock regulation of the normal automaticity of sinoatrial nodal pacemaker cells: bradycardic effects of ivabradine are linked to suppression of intracellular Ca²⁺ cycling.

Authors:  Yael Yaniv; Syevda Sirenko; Bruce D Ziman; Harold A Spurgeon; Victor A Maltsev; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2013-05-05       Impact factor: 5.000

Review 7.  Preclinical results with I(f) current inhibition by ivabradine.

Authors:  Alain Berdeaux
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness.

Authors:  R Lane Brown; Timothy Strassmaier; James D Brady; Jeffrey W Karpen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  [Heart rate reduction as a therapeutic strategy: novel options].

Authors:  U C Hoppe
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

10.  Absence of respiratory effects with ivabradine in patients with asthma.

Authors:  K Suresh Babu; Frantisek Gadzik; Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.